(CercleFinance.com) – Eurobio Scientific today announces the availability of two new proprietary screening tests: either EBX 048 (developed specifically for routine screening of COVID-19 and identification of sub-variants) and EBX 060 (for routine screening of monkeypox, chicken pox and measles viruses).
These new tests, designed and developed by Eurobio Scientific R&D, are produced internally, in Les Ulis (Essonne) and are available in several versions allowing 25, 50, 100, 200 or 600 determinations to be carried out simultaneously.
The two tests are immediately available for hospital and private laboratories, both in France and internationally, specifies the laboratory.